Sourse: TOI
In a landmark verdict that will safeguard the wallets of millions of cancer patients across India, the Madras HC on Monday dismissed a writ petition filed by pharmaceutical giant Novartis, which had challenged the validity of Indian patent laws.

The Swiss pharma maker, along with its Indian subsidiary, moved the Madras HC for it to declare part of the Indian Patent Act unconstitutional, vague and violative of the right to equality, adding that the Act did not comply with Trade Related Intellectual Property Rights (TRIPs) agreement.

Read More....